HIGHLIGHTS
- who: Hanxu Zhang from the Department of Pharmacy, Peking University First Hospital, No8, Xishiku Street, Xicheng District, Beijing, China have published the paper: Circulating miR-320a-3p and miR-483-5p level associated with pharmacokinetic-pharmacodynamic profiles of rivaroxaban, in the Journal: (JOURNAL)
- what: The authors aimed to investigate the association of plasma miRNAs with pharmacokinetic-pharmacodynamic (PK-PD) profiles of rivaroxaban. Based on previous literature, the authors focused on four candidate miRNAs (miR-320a, miR-483-5p, miR-1233, and miR-134) that are associated with cardiovascular and thromboembolic diseases . Above all, the goal . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.